Reference

1. Luppi, Barbara, et al. "pH-sensitive polymeric physical-mixture for possible site-specific delivery of ibuprofen." European journal of pharmaceutics and biopharmaceutics 55.2 (2003): 199-202.
2. Lachman, Leon, Herbert A. Lieberman, and Joseph L. Kanig. The theory and practice of industrial pharmacy. Philadelphia: Lea & Febiger, 1976.
3. Antonin, K. H., et al. "The absorption of human calcitonin from the transverse colon of man." International journal of pharmaceutics 130.1 (1996): 33-39.
4. Tozaki, Hideyuki, et al. "Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon." Journal of pharmaceutical sciences 86.9 (1997): 1016-1021.
5. Van den Mooter, Guy, and Renaat Kinget. "Oral colon-specific drug delivery: a review." Drug delivery 2.2 (1995): 81-93.
6. Prasad, YV Rama, Y. S. R. Krishnaiah, and S. Satyanarayana. "In vitro evaluation of guar gum as a carrier for colon-specific drug delivery." Journal of controlled release 51.2-3 (1998): 281-287.
7. Jain, Vikas, Shikha Jain, and S. C. Mahajan. "Nanomedicines based drug delivery systems for anti-cancer targeting and treatment." Current drug delivery 12.2 (2015): 177-191.
8. Halsas, M., et al. "Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations." Die Pharmazie 56.9 (2001): 718-723.
9. Kinget, Renaat, et al. "Colonic drug targeting." Journal of drug targeting 6.2 (1998): 129-149.
10. Yang, Libo, James S. Chu, and Joseph A. Fix. "Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation." International journal of pharmaceutics 235.1-2 (2002): 1-15.
11. Rathod, S., A. Ram, and G. Thiru. "Colon targeted pulsatile drug delivery: A review." Pharmainfo net 5.2 (2007): 1-11.
12. Kaur, Apninder, et al. "Polymeric drug delivery approaches for colon targeting: A review." Drug Delivery Letters 4.1 (2014): 38-48.
13. Nugent, S. G., et al. "Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs." Gut 48.4 (2001): 571-577.
14. Jose, S., et al. "Colon targeted drug delivery: Different approaches." Journal of young pharmacists 1.1 (2009): 13.
15. Gaurav, Tiwari, et al. "Primary and novel approaches for colon targeted drug delivery-A review." International Journal of Drug Delivery 2.1 (2010): 01-11.
16. Malik, K., et al. "A review on colon targeting drug delivery system: Novel approaches, anatomy and evaluation." The pharma innovation 1.9, Part A (2012): 1.
17. JASRA, KHUSHBOO, et al. "COLON TARGETED DRUG DELIVERY SYSTEM: A SYSTEMIC REVIEW." NeuroQuantology 20.12 (2022): 84.
18. Sarasija, S., and A. Hota. "Colon-specific drug delivery systems." Indian journal of pharmaceutical sciences 62.1 (2000): 1-8.
19. Qureshi, Altamash M., et al. "Colon targeted drug delivery system: A review on current approaches." Indian J Pharm Biol Res 1.4 (2013): 130-47.
20. Pye, G., et al. "Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma." Gut 31.12 (1990): 1355-1357.
21. Wong, Tin Wui, Gaia Colombo, and Fabio Sonvico. "Pectin matrix as oral drug delivery vehicle for colon cancer treatment." Aaps PharmSciTech 12 (2011): 201-214.
22. Leddin, Desmond, et al. "Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening." Canadian Journal of Gastroenterology and Hepatology 18 (2004): 93-99.
23. Qureshi, Altamash M., et al. "Colon targeted drug delivery system: A review on current approaches." Indian J Pharm Biol Res 1.4 (2013): 130-47.
24. Singh, Nishant, and R. C. Khanna. "Colon targeted drug delivery systems-A Potential Approach." The Pharma Innovation 1.2 (2012).
25. Klotz, Ulrich. "Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid." Clinical pharmacokinetics 10.4 (1985): 285-302.
26. Chan, Rosalind P., et al. "Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide." Digestive diseases and sciences 28 (1983): 609-615.
27. Jain, S. K., M. K. Chourasia, and R. Dengre. "Azo polymers for colon targeted drug delivery." Indian journal of pharmaceutical sciences 67.1 (2005): 43-50.
28. Nagpal, Deepika, et al. "Mutual azo prodrug of 5-aminosalicylic acid for colon targeted drug delivery: synthesis, kinetic studies and pharmacological evaluation." Indian journal of pharmaceutical sciences 68.2 (2006)
29. Scheline, Ronald R. "Drug metabolism by intestinal microorganisms." Journal of pharmaceutical sciences 57.12 (1968): 2021-2037.
30. Tanaka, Hiroshi, et al. "Synthesis of doxorubicin-cyclodextrin conjugates." The Journal of Antibiotics 47.9 (1994): 1025-1029.
31. MHASKE, Deepali V., et al. "Synthesis and pharmacological evaluation of cyclodextrin conjugate prodrugs of ibuprofen." Indian journal of pharmaceutical sciences 67.4 (2005): 432-437.
32. Gupta, D., et al. "Synthesis and evaluation of pharmacological activities of cyclodextrin conjugates of methotrexate." Indian journal of pharmaceutical sciences 66.1 (2004): 26-30.
33. Johansen, Marianne, and Claus Larsen. "Stability and kinetics of hydrolysis of metronidazole monosuccinate in aqueous solution and in plasma." International journal of pharmaceutics 21.2 (1984): 201-209.
34. NAKAMURA, Junzo, et al. "A novel prodrug of salicylic acid, salicylic acid-glutamic acid conjugate utilizing hydrolysis in rabbit intestinal microorganisms." Chemical and pharmaceutical bulletin 40.8 (1992): 2164-2168.
35. Brøndsted, Helle, and Jindr?ich Kopec?ek. "Hydrogels for site-specific oral drug delivery: synthesis and characterization." Biomaterials 12.6 (1991): 584-592.
36. Rowe, Raymond C., Paul Sheskey, and Marian Quinn. Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press, 2009.
37. Schroeder, Kenneth W., William J. Tremaine, and Duane M. Ilstrup. "Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis." New England Journal of Medicine 317.26 (1987): 1625-1629.
38. Ashford, Marianne, et al. "An in vivo investigation into the suitability of pH dependent polymers for colonic targeting." International journal of pharmaceutics 95.1-3 (1993): 193-199.
39. Khan, M. S., B. K. Sridhar, and A. Srinatha. "Development and evaluation of pH-dependent micro beads for colon targeting." Indian Journal of pharmaceutical sciences 72.1 (2010): 18.
40. Sahib, Mohanad Naji, Shaymaa Abdalwahed Abdulameer, and A. A. Rasool. "Design and in vitro evaluation of prednisolone tablets as a potential colon delivery system." Asian journal of pharmaceutical and clinical research 2.4 (2009): 84-93.
41. Khan, M. Zahirul I., Helena P. Štedul, and Nevenka Kurjakovi?. "A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit® L100 and Eudragit S100 combinations." Drug Development and industrial pharmacy 26.5 (2000): 549-554.
42. Jose, S., et al. "Multiparticulate system for colon targeted delivery of ondansetron." Indian journal of pharmaceutical sciences 72.1 (2010): 58.
43. Dandagi, P. M., et al. "pH-sensitive mebeverine microspheres for colon delivery." Indian Journal of Pharmaceutical Sciences 71.4 (2009): 464.
44. Kumar, Manoj, et al. "Report on pharmaceutical approaches to colon targeted drug delivery systems." J Pharm Res 3.3 (2010): 157-159.
45. Ishibashi, Takashi, et al. "Design and evaluation of a new capsule-type dosage form for colon-targeted delivery of drugs." International journal of pharmaceutics 168.1 (1998): 31-40.
46. Qureshi, J., et al. "Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma." Indian journal of pharmaceutical sciences 70.3 (2008): 351.
47. Mukesh C. G., Rajesh K. P., Stavan A. N., MaheshR. D. / Pharm. Dev. Technol. 2008. V. 13.P. 447 – 456.
48. Patel, Mayur M., et al. "Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system." Pharmaceutical development and technology 14.1 (2009): 65-72
49. Theeuwes, Felix, George V. Guittard, and Patrick SL Wong. "Delivery of drug to colon by oral disage form." U.S. Patent No. 4,904,474. 27 Feb. 1990.
50. Ofori-Kwakye, Kwabena, and John T. Fell. "Biphasic drug release: the permeability of films containing pectin, chitosan and HPMC." International journal of pharmaceutics 226.1-2 (2001): 139-145.
51. Krishnaiah, Y. S. R., et al. "Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets." J Pharm Pharm Sci 4.3 (2001): 235-43.
52. Prabhu, Prabhakara, et al. "Investigation of colon specificity of novel polymer Khaya gum." Indian J Pharm Educ Res 44 (2010): 56-65.
53. Ravi, V., and TM Pramod Kumar. "Novel colon targeted drug delivery system using natural polymers." Indian journal of pharmaceutical sciences 70.1 (2008): 111. Lenaerts, Vincent M., and Robert Gurny. Bioadhesive drug delivery systems. CRC press, 1989.